Immuneering

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immuneering and other ETFs, options, and stocks.

About IMRX

Immuneering Corp. engages in the development of new medicines which are unlikely to be found by traditional drug discovery methods. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. 

CEO
Benjamin J. Zeskind
CEOBenjamin J. Zeskind
Employees
64
Employees64
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2008
Founded2008
Employees
64
Employees64

IMRX Key Statistics

Market cap
264.71M
Market cap264.71M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
83.96K
Average volume83.96K
High today
$10.59
High today$10.59
Low today
$9.83
Low today$9.83
Open price
$10.15
Open price$10.15
Volume
25.83K
Volume25.83K
52 Week high
$33.25
52 Week high$33.25
52 Week low
$3.74
52 Week low$3.74

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

IMRX Earnings

-$1.61
-$1.07
-$0.54
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 9
ActualExpected Nov 9
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.